<!DOCTYPE HTML>
<!--
	TXT by HTML5 UP
	html5up.net | @ajlkn
	Free for personal and commercial use under the CCA 3.0 license (html5up.net/license)
-->
<html>
	<head>
		<title>Left Sidebar - TXT by HTML5 UP</title>
		<meta charset="utf-8" />
		<link href="https://fonts.googleapis.com/css?family=PT+Serif:400,400i,700,700i" rel="stylesheet">  
		<meta name="viewport" content="width=device-width, initial-scale=1" />
		<!--[if lte IE 8]><script src="assets/js/ie/html5shiv.js"></script><![endif]-->
		<link rel="stylesheet" href="assets/css/main.css" />
		<!--[if lte IE 8]><link rel="stylesheet" href="assets/css/ie8.css" /><![endif]-->
	</head>
	<body>

		<div id="page-wrapper">

			<!-- Header -->
				<header id="header">
					<div class="logo container">
						<div>
							<h1><a href="index.html" id="logo">Wednesday</a></h1>
							<p>11 May</p>
						</div>
					</div>
				</header>

			<!-- Nav -->
				<nav id="nav">
		<ul>
						<li class="current"><a href="index.html">Home</a></li>
						<li>
							<a href="#">Information</a>
							<ul>
								<li><a href="#">Welcome Letter</a></li>
								<li><a href="#">Map</a></li>
								<li>
									<a href="#">Presenters</a>
									<ul>
										<li><a href="#">Poster Presenters</a></li>
										<li><a href="#">E-Posters</a></li>
										<li><a href="#">Poster Map</a></li>
									</ul>
								</li>
								<li><a href="#">Timetable</a></li>
							</ul>
						</li>
						<li><a href="left-sidebar.html">Wednesday</a></li>
						<li><a href="right-sidebar.html">Thursday</a></li>
						<li><a href="no-sidebar.html">Friday</a></li>
						<li><a href="no-sidebar.html">Saturday</a></li>
						<li><a href="no-sidebar.html">Sunday</a></li>
					</ul>
				</nav>



									<!-- Content -->

										<article class="box page-content">


<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta http-equiv="content-type" content="text/html;charset=utf-8"/>
		<title>Monday.html</title>
		<style type="text/css" media="screen"><!--
			tbody, thead, tfoot, tr, td, th {
				border-style : inherit;
				border-width : inherit;
				border-color : inherit;
			}
			td {
				width : 10px;
				height : 5px;
			}
			.leftFloat {
				float : left;
			}
			.rightFloat {
				float : right;
			}
			span.char-style-override-1 {
				font-family : 'Open Sans', sans-serif;
				font-weight : 300;
				letter-spacing: 12px;
				font-style : normal;
				padding-bottom: 15px;
				font-size : 2.5em;
				color : #045292;
			}
			span.char-style-override-2 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.5em;
				font-style : normal;
				font-weight : 300;
			}
			span.char-style-override-3 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.5em;
				font-style : normal;
				font-weight : 600;
			}
			span.char-style-override-4 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.3em;
				font-style : normal;
				font-weight : 600;
			}
			span.char-style-override-5 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.3em;
				font-style : normal;
				font-weight : 300;
			}
			span.char-style-override-6 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.3em;
				font-style : normal;
				font-weight : 300;
			}
			span.char-style-override-7 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1.3em;
				font-style : normal;
				font-weight : 300;
				text-transform : uppercase;
			}
				span.char-style-override-8 {
				font-family : 'Open Sans', sans-serif;
				font-size : 1em;
				font-style : normal;
				font-weight : 300;
			}
			p.No-Paragraph-Style {
				font-family : "Minion Pro", serif;
				font-weight : normal;
				font-style : normal;
				font-size : 1em;
				text-decoration : none;
				font-variant : normal;
				line-height : 1.2;
				text-align : left;
				color : #000000;
				text-indent : 0px;
				margin : 0px;
			}
			p.para-style-override-1 {
				margin-top : 30px;
				padding-top: 12px;
				border-top : 2px solid #045292;
				text-align: justify;
			}
			p.para-style-override-2 {
				margin-top : 9px;
				color: #045292;
			}
			p.para-style-override-3 {
				margin-left: 58px;
				margin-top : 6px;
			}
			p.para-style-override-4 {
				margin-left : 55px;
				margin-right : 0px;
				margin-top : 20px;
				text-indent : -55px;
			}
			p.para-style-override-5 {
				margin-left : 55px;
				margin-top : 3px;
			}
			p.para-style-override-6 {
				margin-left : 55px;
				margin-top : 3px;
			}
			div.Basic-Text-Frame  {
			  margin-left : 28px;
			  margin-right: 20px;
			}
{
			}
		--></style>
	</head>
	</head>
	<body>
		<div id="Tuesday.html" xml:lang="en-US">
			<div class="Basic-Text-Frame">
				<p class="No-Paragraph-Style"><span class="char-style-override-1">Tuesday, July 5, 2016</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">8:00 - 9:00&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">PLENARY SESSION: SKULL BASE</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">P. Stj√§rne </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">269</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">8:00	BASIC ANATOMICAL ASPECTS270</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Castelnuovo </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">8:30	ENDOSCOPIC SKULL BASE SURGERY: WHERE ARE WE NOW AND WHERE ARE WE GOING?271</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A. Stamm </span><span class="char-style-override-5">(Brazil)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:00 - 9:10Exhibition</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SHORT BREAK</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 15: EPOS REVISITED: HOW DO WE DEAL WITH RHINOSINUSITIS?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">V. Lund </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-5">272</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	DEFINITIONS273</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Steinsvag</span><span class="char-style-override-5"> (Norway)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	DIAGNOSTIC WORKUP274</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Hellings </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:47	TREATMENT275</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J. Mullol </span><span class="char-style-override-5">(Spain)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:06	HOW DO WE GO FORWARD IN CRS RESEARCH?276</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">W. Fokkens </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 16: WHAT CAN WE LEARN FROM MISTAKES IN RHINOPLASTIC SURGERY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">H. Saleh </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-5">277</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	FAILURES IN ALAR CORRECTION278</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J.&nbsp;Constantinidis </span><span class="char-style-override-5">(Greece)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	FAILURES IN TIP CORRECTION279</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">I. Tasca </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:46	FAILURES IN  SEPTAL AND DORSAL CORRECTION280</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Haraldsson</span><span class="char-style-override-5"> (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:04	FAILURES IN CORRECTING TIP-LIP JUNCTION281</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Palma </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 17: NOT ANOTHER NOSE-BLEED!</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">D. Visheva </span><span class="char-style-override-5">(Bulgaria)</span><span class="char-style-override-4"></span><span class="char-style-override-5">282</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	TREATMENT ALGORITHM OF NASAL HAEMORRHAGE283</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S. Dheyauldeen </span><span class="char-style-override-5">(Norway)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	HOW TO MANAGE THE BLEEDING IN THE EMERGENCY-ROOM284</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Toll </span><span class="char-style-override-5">(Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:47	LIGATIONS VS EMBOLIZATION285</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Swift </span><span class="char-style-override-5">(United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:06	HOW TO REDUCE PERI-OPERATIVE BLEEDING286</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V.&nbsp;Pundir </span><span class="char-style-override-5">(United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 18: IRS SESSION: JUVENILE NASAL ANGIOFIBROMA</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">M. Onerci </span><span class="char-style-override-5">(Turkey)</span><span class="char-style-override-4"></span><span class="char-style-override-5">287</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	IMAGING FOR ANGIOFIBROMAS288</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">N. Freling </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	ROUTES AND MODES OF SPREAD289</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Kamel </span><span class="char-style-override-5">(Egypt)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:47	EMBOLIZATION - POSSIBILITIES AND DIFFICULTIES290</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L. Borota </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:06	SURGICAL TECHNIQUES291</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Bernal Sprekelsen </span><span class="char-style-override-5">(Spain)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 19: WHAT IS THE LATEST HIGH TECH IN TREATMENT OF CRS?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">Y. Suzuki </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-5">292</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	ROBOTICS AND 3D ENDOSCOPIC SURGERY293</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Caversaccio </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:35	COMPUTER ANALYSIS OF THE FRONTAL RECESS294</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.J. Wormald </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:00	3D IMAGING TECHNOLOGIES AND NEW ALGORITHMS TO EVALUATE INFLAMMATORY VOLUME IN THE NASAL CAVITY AND PARANASAL SINUSES295</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.J. Zinreich </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 20: TECHNIQUE AND OUTCOME IN PITUITARY SURGERY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">A. Stamm </span><span class="char-style-override-5">(Brazil)</span><span class="char-style-override-4"></span><span class="char-style-override-5">296</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	APPROACHES TO THE SELLA297</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">H.R.&nbsp;Briner </span><span class="char-style-override-5">(Switzerland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	TRICKS AND TIPS IN PITUITARY SURGERY298</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Sacks </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:47	SURGERY FOR SECRETING AND NON-SECRETING ADENOMAS299</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Carrau </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:06	OUTCOMES IN PITUITARY SURGERY300</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">O. Fridman-Bengtsson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 21: DO EPITHELIAL CELLS RULE THE NASAL MUCOSAL?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">P. Stj√§rne </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">301</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	EPITHELIAL BARRIER: TIGHT JUNCTIONS AND THEIR BREAKDOWN302</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Soyka </span><span class="char-style-override-5">(Switzerland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:28	ROLE OF INTERLEUKINS IN EPITHELIAL CELL DIFFERENTIATION IN CRS303</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">B. Steelant </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:47	INTRA EPITHELIAL BACTERIA304</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Douglas </span><span class="char-style-override-5">(New Zealand)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:06	IMMUNOCHEMICAL ASPECTS OF MUCOSAL IMMUNITY OF THE NOSE305</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H. Kawauchi </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 16: PATHOPHYSIOLOGY OF CRS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair:</span><span class="char-style-override-4"> C. Bachert </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span><span class="char-style-override-5">306</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	THE POSSIBLE ROLE OF BACTERIAL LINKED PRO-INFLAMMATORY CYTOKINES IN THE FORMATION OF NASAL POLYPS307</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T.&nbsp;Biggs</span><span class="char-style-override-5">, S.&nbsp;Hayes, P.&nbsp;Harries, S.&nbsp;Pender, R.&nbsp;Salib (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:20	PERIOSTIN IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS: COMPARISON OF DIFFERENT MEDICAL TREATMENT OPTIONS 308</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.&nbsp;De Schryver</span><span class="char-style-override-5">, L.&nbsp;Calus, L.&nbsp;Derycke, C.&nbsp;Bachert, T.&nbsp;Van Zele, P.&nbsp;Gevaert (Belgium)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:30	CAN DEFECTS IN EPITHELIAL REGENERATION AND REPAIR CONTRIBUTE TO CHRONIC SINUSITIS? LESSONS LEARNED FROM EHLERS-DANLOS SYNDROME309</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">F.C.P.&nbsp;Valera</span><span class="char-style-override-5">, B.&nbsp;Ibrahim, E.&nbsp;Brochiero, L.&nbsp;Mfuna Endam, M.&nbsp;Desrosiers (Brazil)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:40	THE RELATIONSHIP BETWEEN CHRONIC RHINOSINUSITIS AND METABOLIC SYNDROME310</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">E.J.&nbsp;Lee, </span><span class="char-style-override-4">K.S.&nbsp;Kim</span><span class="char-style-override-5"> (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:50	EFFECTS OF HISTAMINE ON MIGRATION OF NASAL FIBROBLASTS311</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H.M.&nbsp;Lee</span><span class="char-style-override-5">, J.M.&nbsp;Shin, J.H.&nbsp;Kang, J.H.&nbsp;Park, H.J.&nbsp;Kim (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:00	EFFECT OF CORTICOSTEROIDS ON CELL PROLIFERATION IN CONTROL NASAL MUCOSA FIBROBLASTS AND IN FIBROBLASTS FROM PATIENTS WITH CRSWNP AND ASPIRIN-EXACERBATED RESPIRATORY DISEASE.312</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">L.&nbsp;Fern√°ndez-Bertol√≠n, J.&nbsp;Mullol, M.&nbsp;Fuentes-Prado, N.&nbsp;Agell, J.&nbsp;Roca-Ferrer, I.&nbsp;Alobid, C.&nbsp;Picado, </span><span class="char-style-override-4">L.&nbsp;Pujols </span><span class="char-style-override-5">(Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:10	DOXYCYCLINE INHIBITS TGF-</span><span class="char-style-override-7">Œí</span><span class="char-style-override-6">1-INDUCED EXTRACELLULAR MATRIX PRODUCTION IN NASAL POLYP-DERIVED FIBROBLASTS313</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J.M.&nbsp;Shin</span><span class="char-style-override-5">, J.H.&nbsp;Kang, J.H.&nbsp;Park, H.J.&nbsp;Kim, H.M.&nbsp;Lee (Republic of Korea)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 17: PATHOPHYSIOLOGY OF CRS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4"> TBA</span><span class="char-style-override-5">314</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	CYTOKINES IN CRS WITH NASAL POLYPS AND ASTHMA315</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">F.&nbsp;Chen</span><span class="char-style-override-5">, H.&nbsp;Hong, Y.&nbsp;Sun, J.&nbsp;Shi (China)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:20	CHRONIC RHINOSINUSITIS WITH NASAL POLYPS APPEARS TO BE A ‚ÄúSELF-LIMITING DISEASE‚Äù LASTING APPROXIMATELY ELEVEN YEARS316</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Cornet</span><span class="char-style-override-5">, S.&nbsp;Reitsma, G.&nbsp;Adriaensen, W.&nbsp;Fokkens (Netherlands)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:30	REGULATORY T CELLS IN CHRONIC RHINOSINUSITIS317</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Fruth</span><span class="char-style-override-5">, C.&nbsp;Mann, T.&nbsp;Bopp, J.&nbsp;Brieger (Germany)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:40	IMMUNE PROFILE MEMBRANE MODULATION ON BLOOD AND NASAL EOSINOPHILS DURING NASAL POLYPOSIS WITH CONCOMITANT ASTHMA318</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">I.&nbsp;Gengler</span><span class="char-style-override-5">, G.&nbsp;Mortuaire, C.&nbsp;Vandenhende-Szymanski, M.&nbsp;Capron, L.&nbsp;Prin (France)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:50	IL-22/IL-22R1 SIGNALING REGULATES THE PATHOPHYSIOLOGY OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS VIA ALTERATION OF MUC1 EXPRESSION319</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">Y.&nbsp;Noyama</span><span class="char-style-override-5">, M.&nbsp;Okano, M.&nbsp;Hirai, T.&nbsp;Haruna, T.&nbsp;Higaki, S.&nbsp;Kariya, A.&nbsp;Kanda, K.&nbsp;Nishizaki (Japan)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:00	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR AG1478 INHIBITS MUCUS HYPERSECRETION AND NEUTROPHIL INFILTRATION IN AIRWAY EPITHELIUM.320</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Takezawa</span><span class="char-style-override-5">, T.&nbsp;Ogawa, S.&nbsp;Shimizu, T.&nbsp;Shimizu (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:10	ROLE OF VITAMIN D AND ITS RECEPTORS IN PATHOPHYSIOLOGY OF CHRONIC RHINOSINUSITIS321</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Zagor</span><span class="char-style-override-5">, M.&nbsp;Tomaszewska, N.&nbsp;Rusetska, E.&nbsp;Sarnowska, J.&nbsp;Siedlecki, A.&nbsp;Krzeski (Poland)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">9:10 - 10:25&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 18: SMELL, TASTE AND TRIGEMINAL FUNCTION</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">√Ö. K√•gedal </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">322</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:10	A RANDOMISED CONTROLLED TRIAL OF SODIUM CITRATE SPRAY FOR NON-CONDUCTIVE OLFACTORY DISORDERS323</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">C.&nbsp;Philpott,</span><span class="char-style-override-4"> S.&nbsp;Erskine</span><span class="char-style-override-5">, A.&nbsp;Clark, A.&nbsp;Leeper, R.&nbsp;Sharma, S.&nbsp;Patel, G.&nbsp;Murty (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:20	BIOMARKERS IN THE OLFACTORY EPITHELIUM FOR ALZHEIMER&apos;S DISEASE: REALLY USEFUL?324</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">M.D.C.L.&nbsp;Godoy, </span><span class="char-style-override-4">M.A.&nbsp;Fornazieri</span><span class="char-style-override-5">, F.D.R.&nbsp;Pinna, J.M.&nbsp;Farfel, R.L.&nbsp;Voegels (Brazil)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:30	ACUTE TRAUMATIC BRAIN INJURY AND SENSE OF SMELL: THE ROLE OF SMELL ON NEUROPSYCHOLOGICAL OUTCOMES.325</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Langdon</span><span class="char-style-override-5">, S.&nbsp;Laxe, E.&nbsp;Lehrer, F.&nbsp;Mari√±o, I.&nbsp;Alobid, J.&nbsp;Berenguer, S.&nbsp;Centellas, C.&nbsp;Marin, M.&nbsp;Bernabeu, J.&nbsp;Mullol (Spain)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:40	IS ASSESSMENT OF RANDOM ANSWERS ON THE SNIFFIN&apos; STICKS IDENTIFICATION TEST NECESSARY?326</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">D.T.&nbsp;Nguyen</span><span class="char-style-override-5">, M.H.&nbsp;Sonnet, F.&nbsp;AROUS, P.L.&nbsp;NGUYEN-Thi, R.&nbsp;JANKOWSKI (France)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">9:50	EFFECT OF ORAL STEROIDS ON SMELL REDUCTION OR LOSS IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS. FINAL RESULTS327</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5">E.&nbsp;Proimos, </span><span class="char-style-override-4">A.&nbsp;Ladias</span><span class="char-style-override-5">, F.&nbsp;Seferlis, M.&nbsp;Zisoglou, T.&nbsp;Chimona, C.&nbsp;Papadakis (Greece)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:00	USEFULNESS OF MRI SCANNING OF THE OLFACTORY BULB AND VOLUME MEASUREMENT IN PATIENTS WITH OLFACTORY DYSFUNCTION328</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Rombaux</span><span class="char-style-override-5">, T.&nbsp;Duprez, A.&nbsp;Mouraux, P.&nbsp;Balwenge, C.&nbsp;Huart (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">10:10	EFFECT OF OLFACTORY TRAINING IN PATIENTS WITH OLFACTORY DISORDER329</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Ye</span><span class="char-style-override-5">, S.&nbsp;Shin, H.&nbsp;Lee (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">10:25 - 11:00Exhibition</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">COFFEE BREAK, EXHIBITION AND POSTER VIEWING</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 22: HOW TO MANAGE BAD THINGS AND CATASTROPHES IN SINUS SURGERY </span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">E. Stigare </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">330</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	MEDICO LEGAL ASPECTS331</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Setzen</span><span class="char-style-override-5"> (USA)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	HOW TO MANAGE ICA BLEEDING332</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.J. Wormald </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:37	HOW TO AVOID CSF LEAKAGE333</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A. Sama </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:56	ORBITAL DAMAGE334</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Landsberg</span><span class="char-style-override-5"> (Israel)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 23: DEFECTS IN THE ANTERIOR SKULL BASE ‚Äì TIME TO CALL THE PLUMBER!</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">A. Leunig </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-5">335</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	REASONS FOR CSF LEAKAGE336</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">B.&nbsp;Woodworth </span><span class="char-style-override-5">(USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	DIAGNOSIS OF CSF-LEAKAGE337</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Voegels </span><span class="char-style-override-5">(Brazil)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:37	DIFFERENT TECHNIQUES FOR THE PLUMBER338</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R.&nbsp;Casiano</span><span class="char-style-override-5"> (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:56	DIFFERENT MATERIALS FOR THE PLUMBER339</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Bernal-Sprekelsen </span><span class="char-style-override-5">(Spain)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 24: NEW DELIVERY OF STEROIDS TO THE SINONASAL CAVITY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">L. Lundblad </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">340</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	ELUTING STENTS341</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">G.&nbsp;Adriaensen</span><span class="char-style-override-5"> (Netherlands)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	NASAL STEROID IRRIGATIONS342</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">B.&nbsp;Senior</span><span class="char-style-override-5"> (USA)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:37	NEW DEVICES FOR TARGETED DELIVERY OF NASAL  STEROIDS343</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Djupesland </span><span class="char-style-override-5">(Norway)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:56	CLINICAL ALGORITHM FOR NASAL STEROID USE344</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">G. Xu </span><span class="char-style-override-5">(China)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 25: HOW DO WE APPLY 3D SURGERY IN RHINOLOGY?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">M. Rautiainen </span><span class="char-style-override-5">(Finland)</span><span class="char-style-override-4"></span><span class="char-style-override-5">345</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	3D TECHNOLOGY PRIMER346</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Barnes</span><span class="char-style-override-5"> (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:15	3D ENDOSCOPY347</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S. Ahmed </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:30	3D MODELING FROM PHOTOGRAPHY348</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T.&nbsp;Kanzara</span><span class="char-style-override-5"> (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:45	PHOTOSHOP IN RHINOPLASTY349</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Surda </span><span class="char-style-override-5">(Slovakia)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:00	3D MODELING IN LEARNING350</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Barnes</span><span class="char-style-override-5"> (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 26: NON ALLERGIC RHINITIS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">J.S. Lacroix </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span><span class="char-style-override-5">351</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	MECHANISM OF NON-ALLERGIC RHINITIS352</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Smith </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	LOCAL NASAL ALLERGY - CLINICAL RELEVANCE?353</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.L.&nbsp;Segboer </span><span class="char-style-override-5">(Netherlands)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:37	TREATMENT OPTIONS IN NON-ALLERGIC RHINITIS354</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">V. Hox </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:56	WHAT OF NEUROPEPTIDES?355</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L.O.&nbsp;Cardell</span><span class="char-style-override-5"> (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 27: EAACI SESSION: HOW TO SET UP IMMUNOTHERAPY IN YOUR ENT CLINIC</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">R. Moesges </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-5">356</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	HOW TO SET UP IMMUNOTHERAPY IN YOUR ENT CLINIC?357</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Gevaert </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:25	IMMUNOTHERAPY IN POLYSENSITIZED PATIENTS: WHEN, WHY AND HOW?358</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L.&nbsp;Klimek </span><span class="char-style-override-5">(Germany)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:50	SAFE PRACTICE IN SPECIFIC IMMUNOTHERAPY CLINIC. SET UP OF EMERGENCY PROCEDURES359</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Rudenko </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SYMPOSIUM 28: GENETICS IN RHINOLOGY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">M. Bende </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">360</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	OVERVIEW361</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.&nbsp;Toskala</span><span class="char-style-override-5"> (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	DO YOU INHERIT NASAL POLYPOSIS?362</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">A.&nbsp;Bohman </span><span class="char-style-override-5">(Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:37	HAVE WE LEARNED ANYTHING FROM GWA?363</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. Desrosiers </span><span class="char-style-override-5">(Canada)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:56	GENETICS OF  CHRONIC RHINOSINUSITIS364</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Kern </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 19: SMELL, TASTE AND TRIGEMINAL FUNCTION</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">T. Hummel </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-5">365</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	PERMANENT POSTOPERATIVE ANOSMIA- A SYSTEMATIC REVIEW366</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-5"></span><span class="char-style-override-4">N.&nbsp;Alotaibi</span><span class="char-style-override-5">, B.&nbsp;Landis (Switzerland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:12	APPLICABILITY OF THE &quot;SNIFFIN&apos;&apos;STICKS&apos;&apos; TEST IN A NORMAL POPULATION OF SOUTH-KIVU (D.R.CONGO) AND DEVELOPMENT OF CULTURALLY ADAPTED VERSION367</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P.&nbsp;Balungwe</span><span class="char-style-override-5">, C.&nbsp;Huart, A.&nbsp;Mouraux, C.&nbsp;De Toeuf, T.&nbsp;Hummel, G.&nbsp;Mapoli, I.&nbsp;Bufole, R.&nbsp;Matanda, G.&nbsp;Bisimwa, P.&nbsp;Rombaux</span><span class="char-style-override-5"> (Democratic Republic of Congo)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:24	DEVELOPMENT OF A NEW PSYCHOPHYSICAL METHOD TO ASSESS INTRANASAL TRIGEMINAL CHEMOSENSORY FUNCTION368</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Huart</span><span class="char-style-override-5">, T.&nbsp;Hummel, C.&nbsp;K√§hling, C.&nbsp;De Toeuf, I.&nbsp;Konstantinidis, A.&nbsp;Mouraux, P.&nbsp;Rombaux (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:36	THE LOSS OF OLFACTORY FUNCTION CORRELATES WITH MRI BRAIN DAMAGE IN TRAUMATIC BRAIN INJURY369</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Langdon</span><span class="char-style-override-5">, J.&nbsp;Berenguer, E.&nbsp;Lehrer, F.&nbsp;Mari√±o, I.&nbsp;Alobid, S.&nbsp;Laxe, M.&nbsp;Bernabeu, C.&nbsp;Marin, J.&nbsp;Mullol (Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:48	ASSOCIATION OF TRAUMA BRAIN INJURY WITH OLFACTORY DYSFUNCTION IN THE GENERAL POPULATION  (THE OLFACAT STUDY).370</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C.&nbsp;Langdon</span><span class="char-style-override-5">, L.&nbsp;Quint√≥, E.&nbsp;Lehrer, S.&nbsp;Laxe, F.&nbsp;Mari√±o, F.&nbsp;Jaume, S.&nbsp;Centellas, M.&nbsp;Bernal-Sprekelsen, A.&nbsp;Valero, C.&nbsp;Picado, I.&nbsp;Alobid, C.&nbsp;Marin, J.&nbsp;Mullol (Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:00	INTRANASAL SODIUM CITRATE IMPROVES OLFACTION IN POST-VIRAL HYPOSMIA371</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Whitcroft</span><span class="char-style-override-5">, C.&nbsp;Merkonidis, M.&nbsp;Cuevas, A.&nbsp;Haehner, C.&nbsp;Philpott, T.&nbsp;Hummel (Germany)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 20: SNORING AND OSAS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">S. Berg </span><span class="char-style-override-5">(Denmark)</span><span class="char-style-override-4"></span><span class="char-style-override-5">372</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	VOLUMETRIC ANALYSIS OF NASAL SURGERY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA373</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">N.&nbsp;Busaba</span><span class="char-style-override-5">, B.&nbsp;Lin, D.&nbsp;Cui (USA)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:12	THE EFFECT OF JAW THRUST ON OXYGEN SATURATIONS IN THE UNCONSCIOUS PATIENT374</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">H.&nbsp;Elhassan</span><span class="char-style-override-5">, R.&nbsp;Costello, C.&nbsp;Farley, H.&nbsp;Whittet (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:24	THE ASSOCIATION BETWEEN THE SEVERITY OF SLEEP-DISORDERED BREATHING AND BLOOD COAGULABILITY375</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.H.&nbsp;Lee</span><span class="char-style-override-5"> (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:36	PAEDIATRIC OBSTRUCTIVE SLEEP APNEA (OSA) - A STUDY OF 100 PATIENTS IN THE INDIAN SUBCONTINENT ; TO IDENTIFY THE ROLE OF SURGERY IN MILD OSA376</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.S. Soumya</span><span class="char-style-override-5"> (India)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:48	DRUG-INDUCED SLEEP ENDOSCOPY IN THE PEDIATRIC POPULATION: CLINICAL USEFULNESS AND LITERATURE REVIEW377</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">I.&nbsp;Moura</span><span class="char-style-override-5">, S.&nbsp;Decq Mota, T.&nbsp;Gabriel, M.&nbsp;Menezes Peres, C.&nbsp;Adonis, H.C.&nbsp;Loureiro, F.&nbsp;Freire (Portugal)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">12:00	THE ROLES OF ALLERGIC AND NON-ALLERGIC RHINITIS ARE OVERESTIMATED IN THE ASSOCIATION WITH OBSTRUCTIVE SLEEP APNEA-HYPOPNEA SYNDROME378</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Zheng</span><span class="char-style-override-5">, X.&nbsp;Wang, L.&nbsp;Zhang (China)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">11:00 - 12:15&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 21: PREOPERATIVE ASSESSMENT OF RHINOPLASTY PATIENTS AND SELECTION OF PATIENTS FOR SURGERY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">E. Huizing </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span><span class="char-style-override-5">379</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:00	RESPONSIVENESS OF ACOUSTIC RHINOMETRY TO FUNCTIONAL SEPTORHINOPLASTY BY COMPARISON TO RHINOMANOMETRY AND PATIENT-REPORTED OUTCOME MEASURES.380</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">E.&nbsp;Ansari</span><span class="char-style-override-5">, P.&nbsp;Lefebvre, S.&nbsp;Tombu, A.L.&nbsp;Poirrier (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:09	CLINICAL CLASSIFICATION OF UNILATERAL NASAL OBSTRUCTION BY 36,563 MEASUREMENTS AND TOTAL NASAL OBSTRUCTION BY 10,030 MEASUREMENTS WITH 4-PHASE RHINOMANOMETRY381</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M.&nbsp;Argale</span><span class="char-style-override-5">, K.D.&nbsp;Wernecke, H.&nbsp;Behrbohm (Latvia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:18	THE RELATIONSHIP BETWEEN NASAL RESISTANCE TO AIRFLOW AND THE AIRSPACE MINIMAL CROSS-SECTIONAL AREA382</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">G.&nbsp;Garcia</span><span class="char-style-override-5">, B.&nbsp;Hariri, R.&nbsp;Patel, J.&nbsp;Rhee (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:27	A SURVEY OF CURRENT ENT PRACTICE IN THE ASSESSMENT OF NASAL PATENCY383</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T.&nbsp;Jacques</span><span class="char-style-override-5">, P.&nbsp;Andrews, J.&nbsp;Joseph, C.H.&nbsp;Li, L.&nbsp;Nip, T.&nbsp;Leung (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:45	INTERNAL NASAL VALVE: VALIDATION OF A GRADING SYSTEM384</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">S.&nbsp;Ojha</span><span class="char-style-override-5">, J.&nbsp;Joseph, P.&nbsp;Andrews (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">11:54	PSYCHOPHYSICS OF NASAL BREATHING: UNDERSTANDING THE CORRELATION BETWEEN MEASUREMENTS AND SENSING OF NASAL OBSTRUCTION385</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">K.&nbsp;Vogt</span><span class="char-style-override-5"> (Germany)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">12:15 - 14:15Exhibition</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">BREAK, EXHIBITION AND POSTER VIEWING</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">12:30 - 14:00&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INDUSTRY SUPPORTED SESSION</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-8">Session not included in the CME/CPD Programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-8">For Programme details please refer to the Recognition, Acknowledgements &amp; Commercial Support Section in the final programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-8"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 8: WHAT TO DO WHEN NOTHING WORKS IN CRS? </span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">A. Cervin </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span><span class="char-style-override-5">386</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Beule </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">387</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">C. Philpott </span><span class="char-style-override-5">(United Kingdom)</span><span class="char-style-override-4"></span><span class="char-style-override-6">388</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">Z. Soler </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-6">389</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">L. Zhang </span><span class="char-style-override-5">(China)</span><span class="char-style-override-4"></span><span class="char-style-override-6">390</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">L.H. Kalish </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span><span class="char-style-override-6">391</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">S.Y. Lin </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-6">392</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">T. Baudoin </span><span class="char-style-override-5">(Croatia)</span><span class="char-style-override-4"></span><span class="char-style-override-6">393</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 9: ENDOSCOPIC SURGERY OF SINONASAL MALIGNANCIES</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">R. Carrau </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">394</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">I. Witterick </span><span class="char-style-override-5">(Canada)</span><span class="char-style-override-4"></span><span class="char-style-override-6">395</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">M. Onerci </span><span class="char-style-override-5">(Turkey)</span><span class="char-style-override-4"></span><span class="char-style-override-6">396</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J.R. Montserrat-Gili </span><span class="char-style-override-5">(Spain)</span><span class="char-style-override-4"></span><span class="char-style-override-6">397</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">C. Betz </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">398</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Leunig </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">399</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">H. Stammberger </span><span class="char-style-override-5">(Austria)</span><span class="char-style-override-4"></span><span class="char-style-override-6">400</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 10: ORBITAL COMPLICATIONS IN RHINOSINUSITIS ‚Äì WHEN TO DO WHAT?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">F. Baroody </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">401</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">I. Braverman </span><span class="char-style-override-5">(Israel)</span><span class="char-style-override-4"></span><span class="char-style-override-6">402</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">I.R. Herzallah </span><span class="char-style-override-5">(Kingdom of Saudi Arabia)</span><span class="char-style-override-4"></span><span class="char-style-override-6">403</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">M. Desrosiers </span><span class="char-style-override-5">(Canada)</span><span class="char-style-override-4"></span><span class="char-style-override-6">404</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">E. Brozek-Madry </span><span class="char-style-override-5">(Poland)</span><span class="char-style-override-4"></span><span class="char-style-override-6">405</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">B.S. Bleier </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-6">406</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Patel </span><span class="char-style-override-5">(Kenya)</span><span class="char-style-override-4"></span><span class="char-style-override-6">407</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 11: MANAGING OLFACTORY LOSS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">B. Landis </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span><span class="char-style-override-5">408</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">E. Holbrook </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-6">409</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Welge-L√ºssen </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span><span class="char-style-override-6">410</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">M. Bende </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6">411</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">T. Miwa </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-6">412</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">M. Kobayashi </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-6">413</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">P. Rombaux </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span><span class="char-style-override-6">414</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 12: MEASURING THE AIRWAY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">M. Rautiainen </span><span class="char-style-override-5">(Finland)</span><span class="char-style-override-4"></span><span class="char-style-override-5">415</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Hirschberg </span><span class="char-style-override-5">(Hungary)</span><span class="char-style-override-4"></span><span class="char-style-override-6">416</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">G. Ottaviano </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span><span class="char-style-override-6">417</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Ehnhage </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-6">418</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J. Maurer </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">419</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">S.J. Zinreich </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-6">420</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 13: THE CLINICAL PROBLEM OF ISOLATED SPHENOID OPACIFICATION</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">M. Stenkvist-Asplund </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">421</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">E. Serrano </span><span class="char-style-override-5">(France)</span><span class="char-style-override-4"></span><span class="char-style-override-6">422</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">R. Weber </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">423</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">O. Kaschke </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">424</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">N. Yoshida </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-6">425</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">H.J. Welkoborsky </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">426</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">E. Giotakis </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">427</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">ROUND TABLE 14: WHEN THE IMMUNE SYSTEM IS DEFICIENT IN RHINOLOGY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Moderator: </span><span class="char-style-override-4">R. Douglas </span><span class="char-style-override-5">(New Zealand)</span><span class="char-style-override-4"></span><span class="char-style-override-5">428</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Lopatin </span><span class="char-style-override-5">(Russia)</span><span class="char-style-override-4"></span><span class="char-style-override-6">429</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">J.S. Lacroix </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span><span class="char-style-override-6">430</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">A. Gevorgyan </span><span class="char-style-override-5">(Canada)</span><span class="char-style-override-4"></span><span class="char-style-override-6">431</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">K. Aanaes </span><span class="char-style-override-5">(Denmark)</span><span class="char-style-override-4"></span><span class="char-style-override-6">432</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">P. Gevaert </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span><span class="char-style-override-6">433</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	</span><span class="char-style-override-4">T. Shimizu </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-6">434</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 22: TREATMENT OF ALLERGIC RHINITIS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4"> TBA</span><span class="char-style-override-5">435</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:15	MP-AZEFLU PROVIDES EFFECTIVE SYMPTOM RELIEF IRRESPECTIVE OF RESPONSE TO PREVIOUS THERAPY IN PATIENTS WITH MODERATE/SEVERE ALLERGIC RHINITIS436</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">C.&nbsp;Bachert</span><span class="char-style-override-5"> (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:25	RELATIONSHIP BETWEEN SPECIFIC ATOPIC DISEASES AND IN-VITRO ALLERGEN RATES437</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">M.&nbsp;Benninger</span><span class="char-style-override-5">, T.&nbsp;Daly, K.&nbsp;Grafmiller (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:35	DIAGNOSIS IN HOUSE DUST MITE ALLERGY: IS A NASAL PROVOCATION TEST NEEDED ?438</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">B.&nbsp;Haxel </span><span class="char-style-override-5">(Germany)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:45	MOLECULAR MECHANISM OF PMA-INDUCED UP-REGULATION OF INTERLEUKIN-33 GENE EXPRESSION AND THE EFFECT OF SHO-SEIRYU-TO ON IL-33 AND HISTAMINE H1 RECEPTOR GENE EXPRESSION439</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">Y.&nbsp;Kitamura</span><span class="char-style-override-5">, T.&nbsp;Esu, H.&nbsp;Mizuguchi, T.&nbsp;Fujii, H.&nbsp;Fukui, N.&nbsp;Takeda (Japan)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:55	PHYSICIAN HEAL THYSELF: BURDEN OF ALLERGIC RHINITIS AMONGST EAACI MEMBERS.440</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">J.&nbsp;Mullol</span><span class="char-style-override-5">, N.&nbsp;Papadopoulos, P.&nbsp;Hellings, J.&nbsp;Bousquet, G.&nbsp;Scadding, A.&nbsp;Muraro (Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:05	CHANGES IN IMMUNOLOGICAL PARAMETERS IN SUBLINGUAL IMMUNOTHERAPY FOR ALLERGIC RHINITIS441</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">D.&nbsp;Sakurai</span><span class="char-style-override-5">, S.&nbsp;Yonekura, Y.&nbsp;Okamoto (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:15	A RANDOMISED PLACEBO-CONTROLLED TRIAL OF INTRADERMAL ALLERGEN IMMUNOTHERAPY FOR SEASONAL GRASS POLLEN ALLERGY442</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">A.&nbsp;Slovick</span><span class="char-style-override-5">, A.&nbsp;Douiri, S.&nbsp;Durham, S.&nbsp;Till (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:25	EFFICIENT CLINICAL TRIAL RECRUITMENT USING INTEGRATED WEBSITE AND MEDIA-BASED STRATEGY: EXPERIENCE FROM 2 RANDOMISED CONTROLLED TRIALS443</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-5"></span><span class="char-style-override-4">A.&nbsp;Slovick</span><span class="char-style-override-5">, R.&nbsp;Muir, S.&nbsp;Till (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:35	LONG-TREM SUBLINGUAL IMMUNOTHERAPY AND PHENOTYPE OF JAPANESE SEASONAL ALLERGIC RHINITIS.444</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-5"></span><span class="char-style-override-4">T.&nbsp;Yamada</span><span class="char-style-override-5"> (Japan)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 23: CSF-LEAK AND MANAGEMENT OF ANTERIOR SKULL BASE DEFECTS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">E. Stigare </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">445</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:15	EVALUATION OF ENDOSCOPIC REPAIR OF SPONTANEOUS CEREBROSPINAL FLUID RHINORRHEA446</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">A.&nbsp;Bilde</span><span class="char-style-override-5">, S.&nbsp;Ndoni, J.&nbsp;Springborg, K.&nbsp;Fugleholm, L.&nbsp;Poulsgaard, C.&nbsp;Von Buchwald (Denmark)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:26	CEREBROSPINAL FLUID RHINORRHEA SECONDARY TO IDIOPATHIC INTRACRANIAL HYPERTENSION: LONG-TERM OUTCOMES OF ENDOSCOPIC REPAIRS447</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">R.&nbsp;Campbell</span><span class="char-style-override-5">, J.&nbsp;Palmer, N.&nbsp;Adappa, A.&nbsp;Chiu, D.&nbsp;Farquhar, N.&nbsp;Zhao (Australia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:37	SEPTAL FLIP FLAP FOR ANTERIOR SKULL BASE RECONSTRUCTION AFTER ENDOSCOPIC RESECTION OF SINONASAL CANCERS: PRELIMINARY OUTCOMES448</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-5">P.&nbsp;Battaglia, M.&nbsp;Turri-Zanoni, F.&nbsp;De Bernardi, </span><span class="char-style-override-4">P.&nbsp;Dehgani Mobaraki</span><span class="char-style-override-5">, A.&nbsp;Karligkiotis, F.&nbsp;Leone, P.&nbsp;Castelnuovo (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:48	THE USE OF COLLAGEN MATRIX COATED IN FIBRINOGEN AND THROMBIN AS AN ADJUNCT TO ANTERIOR SKULL-BASE CSF-LEAK REPAIR: OUR 5 YEAR EXPERIENCE449</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">R.&nbsp;Hettige</span><span class="char-style-override-5">, A.&nbsp;Addison, P.&nbsp;Martinez-Devesa (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:59	INTRANASAL SODIUM FLUORESCEIN USE IN CSF LEAKS DETECTION AND REPAIR450</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">M.&nbsp;Horoi</span><span class="char-style-override-5">, A.&nbsp;Rodriguez, S.&nbsp;Hassid, C.&nbsp;Ducene, C.&nbsp;De Dorlodot, P.&nbsp;Eloy (Belgium)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:10	THE ROLE OF FRONTAL SINUS DRAF PROCEDURES IN ENDOSCOPIC FRONTOETHMOID DURA REPAIRS451</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">S.&nbsp;Beton</span><span class="char-style-override-5">, H.&nbsp;Basak, S.&nbsp;Mulazimoglu, H.&nbsp;Guliyev, B.&nbsp;Kucuk, I.&nbsp;Yorulmaz, C.&nbsp;Meco (Turkey)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:21	ENDONASAL ENDOSCOPIC PEPAIR OF CSF LEAK RHINORRHEA: AN 18-YEAR EXPERIENCE. WHAT HAVE WE LEARNED?452</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">M.&nbsp;Nersesyan</span><span class="char-style-override-5">, D.&nbsp;Kapitanov, A.&nbsp;Potapov, A.&nbsp;Kravchuk (Russia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:32	A PURELY SYNTHETIC AND BIODEGRADABLE MATERIAL FOR REPAIR OF CSF RHINORRHOEA453</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">P.&nbsp;Surda</span><span class="char-style-override-5">, A.&nbsp;Walker, A.&nbsp;Toma (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">14:15 - 15:45&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 24: ENDOSCOPIC SURGERY OF SKULL BASE TUMOURS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">R. Casiano </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">454</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:15	A CASE SERIES OF ENDOSCOPIC NASOPHARYNGECTOMY FOR UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA455</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">J.&nbsp;Chan</span><span class="char-style-override-5">, D.&nbsp;Lee, E.&nbsp;Wong, S.&nbsp;Chow, C.A.&nbsp;Van Hasselt, A.&nbsp;Vlantis, M.&nbsp;Tong (Hong Kong-China)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:24	PITUITARY SURGERY AND VOLUMETRIC ASSESSMENT OF EXTENT OF RESECTION: A PARADIGM SHIFT IN THE USE OF INTRAOPERATIVE MRI456</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">D.&nbsp;Holzmann</span><span class="char-style-override-5">, C.&nbsp;Serra, J.K.&nbsp;Burkhardt, O.&nbsp;Bozinov, A.&nbsp;Pangalu, A.&nbsp;Valavanis, C.&nbsp;Schmid, L.&nbsp;Regli (Switzerland)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:33	ENDOSCOPIC VERSUS OPEN SURGERY FOR SINONASAL MALIGNANCIES: MAYO CLINIC EXPERIENCE457</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">D.&nbsp;Lal</span><span class="char-style-override-5">, A.&nbsp;Patel, S.&nbsp;Patel (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:42	THE RADIOANATOMY OF ENDONASAL FLAP COVERAGE OF SKULL BASE DEFECTS: A TOOL FOR PREOPERATIVE PLANNING458</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">F.&nbsp;MacArthur</span><span class="char-style-override-5">, G.&nbsp;McGarry (New Zealand)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">14:51	SAFETY AND EFFICACY OF ENDOSCOPIC ENDONASAL APPROACH FOR ESTHESIONEUROBLASTOMA: JAPAN MULTICENTER STUDY459</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">T.&nbsp;Nakagawa</span><span class="char-style-override-5">, S.&nbsp;Tatsunori, K.&nbsp;Satoru, K.&nbsp;Masayoshi, H.&nbsp;Nobuhiro, Y.&nbsp;Hidenori, S.&nbsp;Motohiko, T.&nbsp;Shuho, H.&nbsp;Toyoyuki, S.&nbsp;Tetsuji (Japan)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:00	SINONASAL AND PERIOPERATIVE MORBIDITY FROM A MODIFIED NASOSEPTAL FLAP IN PITUITARY SURGERY460</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">G.&nbsp;Oakley</span><span class="char-style-override-5">, J.&nbsp;Christensen, M.&nbsp;Winder, A.&nbsp;Davidson, B.&nbsp;Jonker, T.&nbsp;Steel, R.&nbsp;Harvey (Australia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:09	PATHOLOGICAL ASSESSMENT OF ENDOSCPIC COMPARTMENT SURGERY FOR INTESTINAL ADENOCARCINOMA OF THE OLFACTORY CLEFT461</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-5">A.&nbsp;Russel, C.&nbsp;Vigouroux, D.T.&nbsp;Nguyen, J.M.&nbsp;Vignaud, B.&nbsp;Toussaint, P.&nbsp;Gallet, </span><span class="char-style-override-4">C.&nbsp;Rumeau</span><span class="char-style-override-5">, R.&nbsp;Jankowski (France)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:18	PROGNOSTIC VALUE OF PRETREATMENT PERIPHERAL BLOOD MARKERS IN PATIENTS WITH PARANASAL SINUS CANCERS: NEUTROPHIL-LYMPHOCYTE RATIO AND PLATELET-LYMPHOCYTE RATIO.462</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">G.&nbsp;Salzano</span><span class="char-style-override-5">, M.&nbsp;Turri-Zanoni, A.&nbsp;Lambertoni, A.&nbsp;Karligkiotis, P.&nbsp;Battaglia, P.&nbsp;Castelnuovo (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:27	ENDOSCOPIC NASOPHARYNGECTOMY FOR RECURRENT NASOPHARYNGEAL CARCINOMA: A REVIEW OF 71 PATIENTS AND PROGNOSTIC FACTORS.463</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">X.&nbsp;Sun</span><span class="char-style-override-5">, L.&nbsp;Juan, W.&nbsp;Huan, Y.&nbsp;Huapeng, W.&nbsp;Jingjing, L.&nbsp;Houyong, G.&nbsp;Yurong, G.&nbsp;Limin, W.&nbsp;Dehui (China)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">15:36	ENDOSCOPIC TRANSMAXILLARY TRANSPTERIGOID CORRIDOR ACCESS TO THE SKULL BASE. PRACTICAL SURGICAL LANDMARKS AND RADIOLOGICAL CORRELATIONS464</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">M.&nbsp;Horoi</span><span class="char-style-override-5">, S.&nbsp;Kampouridis, P.&nbsp;Jissendi, C.&nbsp;Ducene, S.&nbsp;Hassid, A.&nbsp;Rodriguez (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">15:45 - 16:15Exhibition</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">COFFEE BREAK, EXHIBITION AND POSTER VIEWING</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 11: TIPS AND HINTS IN CSF LEAK REPAIR</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">H.R. Briner </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span><span class="char-style-override-6">465</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 12: THE ENDOSCOPIC WAY TO THE ‚ÄúBRAIN‚Äù</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">A. Stamm </span><span class="char-style-override-5">(Brazil)</span><span class="char-style-override-4"></span><span class="char-style-override-6">466</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 13: IMAGING OF THE SKULL BASE ‚Äì INTERPRETATION AND CORRELATION TO ANATOMY</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">N. Freling </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span><span class="char-style-override-6">467</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">DEBATE: LOCAL ALLERGY: REALITY OR FICTION?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">R. Moesges </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-5">468</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	LOCAL ALLERGY - REALITY469</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C. Rondon </span><span class="char-style-override-5">(Spain)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	LOCAL ALLERGY - FICTION470</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">L. Klimek </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	DISCUSSION	</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">DEBATE: CRSsNP TO OPERATE OR NOT TO OPERATE</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">A. Leunig </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-5">471</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	TO OPERATE472</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Jankowski </span><span class="char-style-override-5">(France)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	NOT TO OPERATE473</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">P. Olsson </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	DISCUSSION	</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 14: HOW TO LEARN FUNCTIONAL CORRECTIVE NASAL SURGERY </span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">H. Gassner </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">474</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 15: ADEQUATE INVESTIGATIONS IN THE CRS PATIENT</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">R. Harvey </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span><span class="char-style-override-6">475</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 16:40&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 25: FACIAL PAIN</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">D. Kennedy </span><span class="char-style-override-5">(USA)</span><span class="char-style-override-4"></span><span class="char-style-override-5">476</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:15	VARIANTS OF TRI-ALLELIC SEROTONIN TRANSPORTER GENE-LINKED POLYMORPHIC REGION (5-HTTLPR) IN PATIENTS WITH CHRONIC TENSION-TYPE MID-FACIAL PAIN477</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">A.M.&nbsp;Agius</span><span class="char-style-override-5">, R.&nbsp;Muscat (Malta)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:25	IS FACIAL PAIN A PRESENTING FEATURE OF CHRONIC RHINOSINUSITIS AFFECTING THE FRONTAL SINUS478</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">R.&nbsp;Lakhani</span><span class="char-style-override-5">, C.&nbsp;Hopkins (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 26: RHINITIS MISCELLANEOUS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">C. Sarafoleanu </span><span class="char-style-override-5">(Romania)</span><span class="char-style-override-4"></span><span class="char-style-override-5">479</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:15	RHINITIS SYMPTOMS PREVALENCE AND RISK FACTORS IN CHILDREN AND ADOLESCENTS IN HONG KONG480</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">J.&nbsp;Chan</span><span class="char-style-override-5">, K.&nbsp;Chan, H.K.&nbsp;So, M.&nbsp;Tong, A.&nbsp;Li (Hong Kong- China)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:26	A SYSTEMATIC REVIEW OF RHINITIS IN THE ELITE ATHLETES AND EXERCISE-INDUCED CHANGES IN THE NASAL AIRWAY481</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">P.&nbsp;Surda</span><span class="char-style-override-5">, A.&nbsp;Walker, M.&nbsp;Putala (Netherlands)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:37	CHRONIC HYPERGRAVITY INDUCES ANTIOXIDATIVE AND PROAPOPTOTIC GENE EXPRESSION IN MICE WITH ALLERGIC ASTHMA AND RHINITIS482</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-5">C.S.&nbsp;Park, T.Y.&nbsp;Jang, A.Y.&nbsp;Jung, </span><span class="char-style-override-4">Y.H.&nbsp;Kim</span><span class="char-style-override-5"> (Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:48	ANTI-ALLERGIC EFFECTS OF ANTI-IL-33 IS ASSOCIATED WITH SUPPRESSION OF IMMUNOGLOBULIN LIGHT CHAIN AND INDUCIBLE NITRIC OXIDE SYNTHASE483</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-5">T.Y.&nbsp;Jang, C.S.&nbsp;Park, A.Y.&nbsp;Jung,</span><span class="char-style-override-4"> Y.H.&nbsp;Kim </span><span class="char-style-override-5">(Republic of Korea)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">16:15 - 17:00&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 27: PEDIATRIC RHINOLOGY</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">E. Brozek-Madry </span><span class="char-style-override-5">(Poland)</span><span class="char-style-override-4"></span><span class="char-style-override-5">484</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:15	FUNCTIONAL AND AESTHETIC CORRECTION OF SECONDARY UNILATERAL CLEFT LIP NASAL DEFORMITIES485</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">M.&nbsp;Cohen</span><span class="char-style-override-5"> (USA)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:24	ENDOSCOPIC TREATMENT OF BILATERAL CONGENITAL CHOANAL ATRESIA486</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">P.&nbsp;Farneti</span><span class="char-style-override-5">, V.&nbsp;Sciarretta, G.&nbsp;Macr√¨, P.&nbsp;Tarchini, S.&nbsp;Cantore, E.&nbsp;Pasquini (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:33	ACUTE RHINOSINUSITIS IN IMMUNOSUPPRESSED CHILDREN: DIAGNOSTIC AND THERAPEUTIC MANAGEMENT487</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">A.&nbsp;Ritter</span><span class="char-style-override-5">, S.&nbsp;Fischer, E.&nbsp;Yaniv, T.&nbsp;Hadar, E.&nbsp;Soudry, D.&nbsp;Shai, D.&nbsp;Gilony, G.&nbsp;Bachar (Israel)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:42	ACUTE RHINOSINUSITIS AND ORBITAL COMPLICATIONS ‚Äì A POPULATION BASED STUDY ON INCIDENCE, RISK FACTORS AND CLINICAL OUTCOMES IN CHILDREN YOUNGER THAN FIVE YEARS OF AGE488</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">S.&nbsp;Hultman Dennison</span><span class="char-style-override-5">, L.&nbsp;Schollin Ask, P.&nbsp;Stj√§rne, A.&nbsp;Granath, M.&nbsp;Eriksson, M.&nbsp;Ryd Rinder, A.&nbsp;Lindstrand, S.&nbsp;Srivastava (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">16:51	A PRACTICAL APPROACH TO SAFE AND EFFECTIVE COBLATION REDUCTION OF THE INFERIOR TURBINATES IN THE PAEDIATRIC POPULATION489</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">A.&nbsp;Walker</span><span class="char-style-override-5">, A.&nbsp;Takhar, A.&nbsp;Rachmanidou (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 16: HOW TO ADDRESS MENINGOCELES</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">C. Georgalas </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span><span class="char-style-override-6">490</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 17: HOW TO ACCESS THE FRONTAL SINUS</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">W. Fokkens </span><span class="char-style-override-5">(Netherlands)</span><span class="char-style-override-4"></span><span class="char-style-override-6">491</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall C</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 18: WHAT TO DO WHEN THE NOSE BLEEDS VERY MUCH!</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">T. Van Zele </span><span class="char-style-override-5">(Belgium)</span><span class="char-style-override-4"></span><span class="char-style-override-6">492</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall D</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">DEBATE: ALLERGEN COMPONENTS ‚Äì RELEVANT OR NO?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">R. Pawankar </span><span class="char-style-override-5">(Japan)</span><span class="char-style-override-4"></span><span class="char-style-override-5">493</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	ALLERGEN COMPONENTS - CLINICALLY RELEVANT494</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">M. van Hage </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	ALLERGEN COMPONENTS - NOT CLINICALLY RELEVANT495</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">T. K√ºndig </span><span class="char-style-override-5">(Switzerland)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	DISCUSSION	</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall E</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">DEBATE: CF ‚Äì SURGERY OR NO?</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">O. Kaschke </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-5">496</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	CF - SURGERY497</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">C. von Buchwald </span><span class="char-style-override-5">(Denmark)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	CF - NO SURGERY498</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4">R. Douglas </span><span class="char-style-override-5">(New Zealand)</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">	DISCUSSION	</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall F</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 19: WRITING A PAPER THAT RHINOLOGY WILL ACCEPT</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">S. Carney </span><span class="char-style-override-5">(Australia)</span><span class="char-style-override-4"></span><span class="char-style-override-6">499</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall G</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INSTRUCTIONAL SESSION 20: THE SCIENCE OF ASPIRIN INTOLERANCE DIAGNOSTICS AND TOLERANCE INDUCTION</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">T. Keck </span><span class="char-style-override-5">(Austria)</span><span class="char-style-override-4"></span><span class="char-style-override-6">500</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-4">A. Rozsasi </span><span class="char-style-override-5">(Germany)</span><span class="char-style-override-4"></span><span class="char-style-override-6">501</span></p>
				<p class="No-Paragraph-Style para-style-override-3"/>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall H</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 28: ORBIT AND LACRIMAL SYSTEM</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">K. Steensland </span><span class="char-style-override-5">(Sweden)</span><span class="char-style-override-4"></span><span class="char-style-override-5">502</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:00	ENDOSCOPIC TRANSNASAL DACRYOCYSTORHINOSTOMY503</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">P.&nbsp;Farneti</span><span class="char-style-override-5">, V.&nbsp;Sciarretta, G.&nbsp;Gramellini, G.&nbsp;Macr√¨, V.&nbsp;Profazio, S.&nbsp;Guidelli Guidi, E.&nbsp;Pasquini (Italy)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:09	ORBITAL VOLUME AND SURFACE AREA BASED ON HIGH-RESOLUTION COMPUTED TOMOGRAPHY OF HUMAN CADAVERS504</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">U.&nbsp;Felding</span><span class="char-style-override-5">, S.&nbsp;Bloch, C.V.&nbsp;Buchwald (Denmark)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:18	EXPANDING THE LIMITS OF ENDOSCOPIC INTRAORBITAL TUMOR RESECTION USING 3-DIMENSIONAL RECONSTRUCTION505</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">L.&nbsp;Gregorio</span><span class="char-style-override-5">, M.&nbsp;Miyake, S.&nbsp;Freitag, N.&nbsp;Busaba, B.&nbsp;Bleier (Brazil)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:27	BALANCED (MEDIAL ENDOSCOPIC AND LATERAL TRANSCUTANEOUS) ORBITAL DECOMPRESSION IN GRAVE‚ÄôS ORBITOPATHY506</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-5"></span><span class="char-style-override-4">E.&nbsp;Hernandez-Garcia</span><span class="char-style-override-5">, J.J.&nbsp;San Roman, R.&nbsp;Gonzalez, A.&nbsp;Nogueira, I.&nbsp;Genol, N.&nbsp;Toledano, G.&nbsp;Plaza (Spain)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:36	BLOWOUT FRACTURES ‚Äì DEVELOPMENT OF SEQUELAE IN PATIENTS RECEIVING NON-SURGICAL TREATMENT507</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">B.&nbsp;Alinasab</span><span class="char-style-override-5"> (Sweden)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:30&emsp;Hall I</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 29: SKULL BASE SURGERY MISCELLANEOUS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">I. Dallan </span><span class="char-style-override-5">(Italy)</span><span class="char-style-override-4"></span><span class="char-style-override-5">508</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:00	ENDOSCOPIC ENDONASAL LANDMARKS TO THE DESCENDING PALATINE CANAL:   A RADIOGRAPHIC STUDY509</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">R.&nbsp;Campbell</span><span class="char-style-override-5">, R.&nbsp;Carrau, D.&nbsp;Prevedello, A.&nbsp;Solares, E.&nbsp;Mason (Australia)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:10	TYPE III FRONTAL SINUSOTOMY: SURGICAL TECHNIQUE, INDICATIONS, OUTCOMES, A MULTIUNIVERSITY RETROSPECTIVE STUDY OF 120 CASES510</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">P.&nbsp;Eloy</span><span class="char-style-override-5"> (Belgium)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:20	POSTOPERATIVE SINONASAL CRUSTING IN SELLAR RECONSTRUCTION WITH AVASCULAR FREE GRAFTS: MUCOSAL AUTOGRAFT VERSUS ACELLULAR DERMAL ALLOGRAFT511</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">C.R.&nbsp;Roxbury</span><span class="char-style-override-5">, M.&nbsp;Ramanathan, M.&nbsp;Lim, M.&nbsp;Ishii, G.L.&nbsp;Gallia, D.D.&nbsp;Reh (USA)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:00 - 17:45&emsp;Hall J</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">FREE PAPER SESSION 30: RHINOLOGY MISCELLANEOUS</span></p>
				<p class="No-Paragraph-Style para-style-override-3"><span class="char-style-override-4"></span><span class="char-style-override-5">Chair: </span><span class="char-style-override-4">G. Xu </span><span class="char-style-override-5">(China)</span><span class="char-style-override-4"></span><span class="char-style-override-5">512</span><span class="char-style-override-4"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:00	THE ROLE OF IMAGING IN THE PRE-OPERATIVE ASSESSMENT OF PATIENTS WITH NASAL OBSTRUCTION AND SEPTAL DEVIATION513</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">N.&nbsp;Carmel Neiderman</span><span class="char-style-override-5">, D.M.&nbsp;Fliss, A.&nbsp;Safadi, B.&nbsp;Ringel, A.&nbsp;Abergel (Israel)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:05	INCREASING PRESSURES WITHIN THE ENT DEPARTMENT?514</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">R.&nbsp;Costello</span><span class="char-style-override-5">, S.&nbsp;Quine (United Kingdom)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:10	AN END-USER SURVEY TO DETERMINE PATIENT EXPECTATIONS WITH REGARD TO THE ASSESSMENT OF NASAL PATENCY515</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">R.&nbsp;Gupta</span><span class="char-style-override-5">, P.&nbsp;Andrews, J.&nbsp;Joseph, C.H.&nbsp;Li, T.&nbsp;Leung (United Kingdom)</span><span class="char-style-override-5"></span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:15	PATIENT INJURIES IN OPERATIVE RHINOLOGY DURING A TEN-YEAR PERIOD: REVIEW OF NATIONAL PATIENT INSURANCE CHARTS516</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-5">P.&nbsp;Helmi√∂, L.M.&nbsp;Aaltonen, </span><span class="char-style-override-4">K.&nbsp;Blomgren</span><span class="char-style-override-5"> (Finland)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:20	HIGH-DEFINITION VIDEO TELESCOPIC RHINOPLASTY517</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">T.&nbsp;Losano</span><span class="char-style-override-5">, C.&nbsp;La Melia, G.&nbsp;Ceroni Compadretti, I.&nbsp;Tasca (Italy)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:25	NEGLECTED DIABETES MELLITUS AND RHINOCEREBRAL MUCORMYCOSIS518</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">A.&nbsp;Milioni</span><span class="char-style-override-5">, A.&nbsp;Karatzanis, E.&nbsp;Prokopakis, E.&nbsp;Fountakis, A.&nbsp;Kaprana, G.&nbsp;Velegrakis (Greece)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:30	SINONASAL INVERTED PAPILLOMA: COMPARING GROUPS WITH REOCCURRENCE VS. NO REOCCURRENCE - FAILURE ANALYSIS FOR ENDOSCOPIC ENDONASAL APPROACH519</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">J.&nbsp;Urbancic</span><span class="char-style-override-5">, T.&nbsp;Soklic Kosak, K.&nbsp;Jenko, D.&nbsp;Gluvajic, K.&nbsp;Rainer, I.&nbsp;Borsos (Slovenia)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:35	ANALYSIS OF &quot;LOOPS&quot; IN 4-PHASE-RHINOMANOMETRY BY SIMULATION WITH AN &quot;ARTIFICIAL NOSE&quot;520</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-5"></span><span class="char-style-override-4">K.&nbsp;Vogt</span><span class="char-style-override-5">, H.&nbsp;Felix (Germany)</span></p>
				<p class="No-Paragraph-Style para-style-override-4"><span class="char-style-override-6">17:40	SINO-NASAL LESIONS: CHOOSING THE APPROPRIATE SURGICAL APPROACH521</span></p>
				<p class="No-Paragraph-Style para-style-override-6"><span class="char-style-override-4">A.&nbsp;Yakirevitch</span><span class="char-style-override-5">, G.&nbsp;Nakache, L.&nbsp;Bedrin (Israel)</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:45 - 18:00Exhibition</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">SHORT BREAK</span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">18:00 - 19:30&emsp;Hall A</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INDUSTRY SUPPORTED SESSION</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-8">Session not included in the CME/CPD Programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-8">For Programme details please refer to the Recognition, Acknowledgements &amp; Commercial Support Section in the final programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-8"></span></p>
				<p class="No-Paragraph-Style para-style-override-1"><span class="char-style-override-2">17:45 - 18:45&emsp;Hall B</span></p>
				<p class="No-Paragraph-Style para-style-override-2"><span class="char-style-override-3">INDUSTRY SUPPORTED SESSION</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-8">Session not included in the CME/CPD Programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-8">For Programme details please refer to the Recognition, Acknowledgements &amp; Commercial Support Section in the final programme.</span></p>
				<p class="No-Paragraph-Style para-style-override-5"><span class="char-style-override-8"></span></p>
			</div>
		</div>
	</body>
</html>